These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 32645702)
1. Clinicopathological Relevance and Prognostic Value of Androgen Receptor in Mammary Paget's Disease with Underlying Invasive Ductal Carcinoma. Zhang M; Meng X; Guo C; Liu J; Xing Z; Wang X; Wang X Oncol Res Treat; 2020; 43(7-8):346-353. PubMed ID: 32645702 [TBL] [Abstract][Full Text] [Related]
2. Correlation analysis between androgen receptor and the clinicopathological features and prognosis of mammary Paget's disease. Wu Y; Sun S; Huang Y; Xiao M; Zhao X; Lu X; Xia B; Qiao K; Zhang S; Wu Q; Xiong J; Cheng S; Song Y J Cancer Res Clin Oncol; 2023 Mar; 149(3):1175-1184. PubMed ID: 35364707 [TBL] [Abstract][Full Text] [Related]
3. The effect of Paget disease on axillary lymph node metastases and survival in invasive ductal carcinoma. Wong SM; Freedman RA; Sagara Y; Stamell EF; Desantis SD; Barry WT; Golshan M Cancer; 2015 Dec; 121(24):4333-40. PubMed ID: 26376021 [TBL] [Abstract][Full Text] [Related]
4. [Young mammary Paget's disease patients with underlying breast invasive ductal carcinoma: clinicopathological features and prognosis]. Zhang ML; Wang X; Xing ZY; Liu JQ; Wang X Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):425-429. PubMed ID: 35615799 [No Abstract] [Full Text] [Related]
5. Different panels of markers should be used to predict mammary Paget's disease associated with in situ or invasive ductal carcinoma of the breast. Lester T; Wang J; Bourne P; Yang Q; Fu L; Tang P Ann Clin Lab Sci; 2009; 39(1):17-24. PubMed ID: 19201736 [TBL] [Abstract][Full Text] [Related]
6. Frequent expression of the breast differentiation antigen NY-BR-1 in mammary and extramammary Paget's disease. Giger O; Caduff R; O'Meara A; Diener PA; Knuth A; Jäger D; Moch H; Varga Z Pathol Int; 2010 Nov; 60(11):726-34. PubMed ID: 20946522 [TBL] [Abstract][Full Text] [Related]
7. Expression of Cox-2 and Bcl-2 in Paget's disease of the breast. Alikanoglu AS; Yildirim M; Suren D; Tutus B; Kaya V; Topal CS; Keser S; Karadayi AN; Kapucuoglu FN; Ayva S; Gunduz S Asian Pac J Cancer Prev; 2015; 16(3):1041-5. PubMed ID: 25735328 [TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological characteristics and prognosis analysis with Paget's disease of the breast]. Wang J; Yu WJ; Wang X; Wang X; Tian YT Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):523-527. PubMed ID: 30060361 [No Abstract] [Full Text] [Related]
9. Surgical treatment in Paget's disease with invasive ductal carcinoma: an observational study based on SEER. Wu Q; Ding X; Li J; Sun S; Zhu S; Wu J; Liu Q; Yao F; Sun S Sci Rep; 2017 Apr; 7():45510. PubMed ID: 28422090 [TBL] [Abstract][Full Text] [Related]
10. Breast-Conserving Surgery in Patients With Mammary Paget's Disease. Yao Y; Sun L; Meng Y; Zhuang Y; Zhao L; Yu Q; Si C J Surg Res; 2019 Sep; 241():178-187. PubMed ID: 31026796 [TBL] [Abstract][Full Text] [Related]
11. Androgen receptors are frequently expressed in mammary and extramammary Paget's disease. Liegl B; Horn LC; Moinfar F Mod Pathol; 2005 Oct; 18(10):1283-8. PubMed ID: 15920545 [TBL] [Abstract][Full Text] [Related]
12. Minimally invasive mammary Paget's disease without an underlying breast carcinoma. Hanna M; Jaffer S; Bleiweiss IJ; Nayak A Virchows Arch; 2013 Sep; 463(3):471-3. PubMed ID: 23851623 [No Abstract] [Full Text] [Related]
13. Comprehensive prognostic report of the Japanese Breast Cancer Society Registry in 2004. Kinoshita T; Fukui N; Anan K; Iwamoto T; Niikura N; Kawai M; Hayashi N; Tsugawa K; Aogi K; Ishida T; Masuoka H; Masuda S; Iijima K; Nakamura S; Tokuda Y Breast Cancer; 2016 Jan; 23(1):39-49. PubMed ID: 26446041 [No Abstract] [Full Text] [Related]
14. Mammary and extramammary Paget's disease: an immunohistochemical study of 83 cases. Liegl B; Leibl S; Gogg-Kamerer M; Tessaro B; Horn LC; Moinfar F Histopathology; 2007 Mar; 50(4):439-47. PubMed ID: 17448019 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the biomarkers for targeted therapies in primary extra-mammary and mammary Paget's disease. Gatalica Z; Vranic S; Krušlin B; Poorman K; Stafford P; Kacerovska D; Senarathne W; Florento E; Contreras E; Leary A; Choi A; In GK Cancer Med; 2020 Feb; 9(4):1441-1450. PubMed ID: 31899853 [TBL] [Abstract][Full Text] [Related]
16. Differential expression of mucin genes in mammary and extramammary Paget's disease. Kuan SF; Montag AG; Hart J; Krausz T; Recant W Am J Surg Pathol; 2001 Dec; 25(12):1469-77. PubMed ID: 11717535 [TBL] [Abstract][Full Text] [Related]
17. Study of neu-protein expression in mammary Paget's disease with and without underlying breast carcinoma and in extramammary Paget's disease. Meissner K; Rivière A; Haupt G; Löning T Am J Pathol; 1990 Dec; 137(6):1305-9. PubMed ID: 1701961 [TBL] [Abstract][Full Text] [Related]
18. Invasive ductal carcinoma with coexisting ductal carcinoma in situ (IDC/DCIS) versus pure invasive ductal carcinoma (IDC): a comparison of clinicopathological characteristics, molecular subtypes, and clinical outcomes. Goh CW; Wu J; Ding S; Lin C; Chen X; Huang O; Chen W; Li Y; Shen K; Zhu L J Cancer Res Clin Oncol; 2019 Jul; 145(7):1877-1886. PubMed ID: 31089799 [TBL] [Abstract][Full Text] [Related]
19. Comparative study of breast cancer with or without concomitant Paget disease: An analysis of the SEER database. Chen S; Chen H; Yi Y; Jiang X; Lei H; Luo X; Chen Y; Liu S; Yuan D; Jia X; Li J Cancer Med; 2019 Jul; 8(8):4043-4054. PubMed ID: 31134761 [TBL] [Abstract][Full Text] [Related]
20. [Comparative immunohistochemical study of invasive duct carcinoma and Paget's disease of the breast with c-erbB-2 overexpression]. Petrov SV; Raskin GA; Khasanov RSh; Tsyplakov DE Arkh Patol; 2006; 68(5):10-4. PubMed ID: 17144522 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]